Lamotrigine Tablet, Chewable
Product Images NDC 65862-362

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 65862-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine Tablets (chewable, Dispersible) (Lamotrigine Fig1)

A Kaplan-Meier survival curve depicting the cumulative proportion of patients experiencing mood episodes over time (weeks) in a clinical trial comparing Lamotrigine to placebo. The vertical axis shows failure probability percentage, while the horizontal axis shows weeks, with censored data points marked.*

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Fig2)

A Kaplan-Meier curve chart estimating the cumulative proportion of patients experiencing a mood episode over approximately 80 weeks. The chart compares failure probability percentages between Lamotrigine and Placebo groups, indicating time on the horizontal axis (weeks) and failure probability on the vertical axis (%). The graph includes censored data points.*

FDA Label Image

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Fig3)

This image shows a description panel for Lamotrigine tablets for oral suspension in 5 mg and 25 mg strengths. It includes tablet identification details: the 5 mg tablet is white to off-white, debossed with "D" on one side and "98" on the other; the 25 mg tablet is white to off-white, debossed with "D99" on one side and plain on the other side.*

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablets Bottle))

Label for Lamotrigine Tablets for Oral Suspension, USP 5 mg, chewable tablets in a bottle of 100 count. The label indicates Lamotrigine USP 5 mg per tablet, with administration instructions for swallowing whole, chewing, or dispersing in water or juice. Distributed by Aurobindo Pharma USA, Inc., Manufactured in India. Includes storage directions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Lamotrigine Tablets for Oral Suspension, USP 5 mg. The label indicates the product contains 100 tablets (10 x 10 unit-dose) and is labeled Rx only. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Label for Lamotrigine Tablets for Oral Suspension, USP, 25 mg chewable tablets, packaged in a bottle of 100 tablets. The label states the product is Rx only and manufactured by Aurobindo Pharma Limited. It includes storage instructions, directions on swallowing the tablets whole, chewed, or dispersed, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (10 x 10 Unit-dose))

Carton packaging label for Lamotrigine Tablets for Oral Suspension USP, 25 mg, chewable tablets. The label indicates 100 tablets (10 x 10 unit-dose) and notes that tablets may be swallowed whole, chewed, or dispersed in water or diluted fruit juice. The product is distributed by Aurobindo Pharma USA, Inc. and made in India.*

FDA Label Image

Chemical Structure (Lamotrigine Str)

Chemical structure of Lamotrigine showing a dichlorophenyl group attached to a triazine ring with two amino groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.